Your browser doesn't support javascript.
loading
Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies.
Ryan, Finola; Cole-Hamilton, Joanna; Dandamudi, Niharika; Futschik, Matthias E; Needham, Alexander; Saquib, Rida; Kulasegaran-Shylini, Raghavendran; Blandford, Edward; Kidd, Michael; O'Moore, Éamonn; Hall, Ian; Sudhanva, Malur; Klapper, Paul; Dodgson, Andrew; Moore, Adam; Duke, Madeleine; Tunkel, Sarah; Kenny, Chris; Fowler, Tom.
Afiliación
  • Ryan F; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Cole-Hamilton J; King's College Hospital NHS Foundation Trust, London, UK.
  • Dandamudi N; Division of Surgery & Interventional Science, University College London, London, UK.
  • Futschik ME; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Needham A; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Saquib R; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Kulasegaran-Shylini R; School of Biomedical Sciences, Faculty of Health, University of Plymouth, Plymouth, UK.
  • Blandford E; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Kidd M; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • O'Moore É; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Hall I; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Sudhanva M; UKHSA Regional Laboratory, Birmingham, UK.
  • Klapper P; National Health Protection Office, HSE, Dublin, D01 A4A3, Ireland.
  • Dodgson A; Department of Mathematics, The University of Manchester, Manchester, UK.
  • Moore A; Advanced Analytics, Analytics & Data Science, UK Health Security Agency, London, UK.
  • Duke M; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Tunkel S; King's College Hospital NHS Foundation Trust, London, UK.
  • Kenny C; Public Health and Clinical Oversight (PHCO), Clinical and Public Health Group, UK Health Security Agency, 10 South Colonade, Canary Wharf, London, E14 4PU, UK.
  • Fowler T; Clinical Virology, Division of Evolution, Infections and Genomics, University of Manchester, Manchester, UK.
Sci Rep ; 14(1): 7475, 2024 03 29.
Article en En | MEDLINE | ID: mdl-38553484
ABSTRACT
To detect SARS-CoV-2 amongst asymptomatic care home staff in England, a dual-technology weekly testing regime was introduced on 23 December 2020. A lateral flow device (LFD) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) test were taken on the same day (day 0) and a midweek LFD test was taken three to four days later. We evaluated the effectiveness of using dual-technology to detect SARS-CoV-2 between December 2020 to April 2021. Viral concentrations derived from qRT-PCR were used to determine the probable stage of infection and likely level of infectiousness. Day 0 PCR detected 1,493 cases of COVID-19, of which 53% were in the early stages of infection with little to no risk of transmission. Day 0 LFD detected 83% of cases that were highly likely to be infectious. On average, LFD results were received 46.3 h earlier than PCR, enabling removal of likely infectious staff from the workplace quicker than by weekly PCR alone. Demonstrating the rapidity of LFDs to detect highly infectious cases could be combined with the ability of PCR to detect cases in the very early stages of infection. In practice, asymptomatic care home staff were removed from the workplace earlier, breaking potential chains of transmission.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido